Brief Report: Prognostic Value of KRAS/TP53 Status for Overall Survival in First-Line Mono-Immunotherapy and Chemo-Immunotherapy Treated Patients with Non-Squamous Non-Small Cell Lung Cancer in the Netherlands
JTO Clinical and Research Reports(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined